The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Medulloblastoma Comprises Four Distinct Molecular Variants
Open accessAbstract
Purpose: Recent genomic approaches have suggested the existence of multiple distinct subtypes of medulloblastoma. We studied a large cohort of medulloblastomas to determine how many subgroups of the disease exist, how they differ, and the extent of overlap between subgroups. Methods: We determined gene expression profiles and DNA copy number aberrations for 103 primary medulloblastomas. Bioinformatic tools were used for class discovery of medulloblastoma subgroups based on the most informative genes in the data set. Immunohistochemistry for subgroup-specific signature genes was used to determine subgroup affiliation for 294 nonoverlapping medulloblastomas on two independent tissue microarrays. Results: Multiple unsupervised analyses of transcriptional profiles identified the following four distinct, nonoverlapping molecular variants: WNT, SHH, group C, and group D. Supervised analysis of these four subgroups revealed significant subgroup-specific demographics, histology, metastatic status, and DNA copy number aberrations. Immunohistochemistry for DKK1 (WNT), SFRP1 (SHH), NPR3 (group C), and KCNA1 (group D) could reliably and uniquely classify formalin-fixed medulloblastomas in approximately 98% of patients. Group C patients (NPR3-positive tumors) exhibited a significantly diminished progression-free and overall survival irrespective of their metastatic status. Conclusion: Our integrative genomics approach to a large cohort of medulloblastomas has identified four disparate subgroups with distinct demographics, clinical presentation, transcriptional profiles, genetic abnormalities, and clinical outcome. Medulloblastomas can be reliably assigned to subgroups through immunohistochemistry, thereby making medulloblastoma subclassification widely available. Future research on medulloblastoma and the development of clinical trials should take into consideration these four distinct types of medulloblastoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Hubert, L., & Arabie, P. (1985) · Journal of Classification · doi:10.1007/bf01908075 · Cited by 8,219
Diagnosis of multiple cancer types by shrunken centroids of gene expression
Tibshirani, R., Hastie, T., Narasimhan, B., & Chu, G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082099299 · Cited by 2,930
Prediction of central nervous system embryonal tumour outcome based on gene expression
Pomeroy, S. L., Tamayo, P., Gaasenbeek, M., Sturla, L. M., Angelo, M., McLaughlin, M. E., Kim, J. Y. H., Goumnerova, L. C., Black, P. M., Lau, C., et al. (2002) · Nature · doi:10.1038/415436a · Cited by 2,371
Metagenes and molecular pattern discovery using matrix factorization
Brunet, J.-P., Tamayo, P., Golub, T. R., & Mesirov, J. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308531101 · Cited by 2,183
Beroukhim, R., Getz, G., Nghiemphu, L., Barretina, J., Hsueh, T., Linhart, D., Vivanco, I., Lee, J. C., Huang, J. H., Alexander, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710052104 · Cited by 1,075
Gajjar, A., Chintagumpala, M., Ashley, D., Kellie, S., Kun, L. E., Merchant, T. E., Woo, S., Wheeler, G., Ahern, V., Krasin, M. J., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70867-1 · Cited by 951
Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
Biegel, J. A., Zhou, J. Y., RORKE, L. B., Stenstrom, C., Wainwright, L. M., & Fogelgren, B. (1999) · PubMed · Cited by 836
Kool, M., Koster, J., Bunt, J., Hasselt, N. E., Lakeman, A., van Sluis, P., Troost, D., Meeteren, N. S.-V., Caron, H. N., Cloos, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003088 · Cited by 722
Self-citationGenomics Identifies Medulloblastoma Subgroups That Are Enriched for Specific Genetic Alterations
Thompson, M. C., Fuller, C., Hogg, T. L., Dalton, J., Finkelstein, D., Lau, C. C., Chintagumpala, M., Adesina, A., Ashley, D. M., Kellie, S. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.4974 · Cited by 668
Self-citationSubclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets
Hoshida, Y., Brunet, J.-P., Tamayo, P., Golub, T. R., & Mesirov, J. P. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001195 · Cited by 614
Ellison, D. W., Onilude, O. E., Lindsey, J. C., Lusher, M. E., Weston, C. L., Taylor, R. E., Pearson, A. D., & Clifford, S. C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.5479 · Cited by 435
Self-citationNorthcott, P. A., Nakahara, Y., Wu, X., Feuk, L., Ellison, D. W., Croul, S., Mack, S., Kongkham, P. N., Peacock, J., Dubuc, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.336 · Cited by 412
Self-citationPfister, S., Remke, M., Benner, A., Mendrzyk, F., Toedt, G., Felsberg, J., Wittmann, A., Devens, F., Gerber, N. U., Joos, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9432 · Cited by 293
Self-citationNorthcott, P. A., Fernandez-L, A., Hagan, J. P., Ellison, D. W., Grajkowska, W., Gillespie, Y., Grundy, R., Van Meter, T., Rutka, J. T., Croce, C. M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4710 · Cited by 289
Self-citationGajjar, A., Hernan, R., Kocak, M., Fuller, C., Lee, Y., McKinnon, P. J., Wallace, D., Lau, C., Chintagumpala, M., Ashley, D. M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.032 · Cited by 279
Clifford, S. C., Lusher, M. E., Lindsey, J. C., Langdon, J. A., Gilbertson, R. J., Straughton, D., & Ellison, D. W. (2006) · Cell Cycle · doi:10.4161/cc.5.22.3446 · Cited by 270
Self-citationTrkC Expression Predicts Good Clinical Outcome in Primitive Neuroectodermal Brain Tumors
Grotzer, M. A., Janss, A. J., Fung, K.-M., Biegel, J. A., Sutton, L. N., Rorke, L. B., Zhao, H., Cnaan, A., Phillips, P. C., Lee, V. M.-Y., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1027 · Cited by 223
Fattet, S., Haberler, C., Legoix, P., Varlet, P., Lellouch‐Tubiana, A., Lair, S., Manie, E., Raquin, M., Bours, D., Carpentier, S., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2514 · Cited by 193
Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma
Gilbertson, R. J., Perry, R., Kelly, P. J., Pearson, A. D. J., & Lunec, J. (1997) · PubMed · doi:10.25405/ncl.34590669 · Cited by 185
Clinical and molecular stratification of disease risk in medulloblastoma
Gilbertson, R., Wickramasinghe, C., Hernan, R., Balaji, V, Hunt, D., Jones-Wallace, D., Crolla, J., Perry, R., Lunec, J., Pearson, A., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1987 · Cited by 168
Grotzer, M. A., Hogarty, M. D., Janss, A. J., Liu, X., Zhao, H., Eggert, A., Sutton, L. N., RORKE, L. B., Brodeur, G. M., & Phillips∥, P. C. (2001) · PubMed · Cited by 168
Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy
Rutkowski, S., Gerber, N. U., von Hoff, K., Gnekow, A., Bode, U., Graf, N., Berthold, F., Henze, G., Wolff, J. E. A., Warmuth-Metz, M., et al. (2009) · Neuro-Oncology · doi:10.1215/15228517-2008-084 · Cited by 166
Di, C., Liao, S., Adamson, D. C., Parrett, T. J., Broderick, D. K., Shi, Q., Lengauer, C., Cummins, J. M., Velculescu, V. E., Fults, D. W., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.919.65.3 · Cited by 160
McManamy, C. S., Pears, J., Weston, C. L., Hanzely, Z., Ironside, J. W., Taylor, R. E., Grundy, R. G., Clifford, S. C., & Ellison, D. W. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00058.x · Cited by 144
Self-citationNeben, K., Korshunov, A., Benner, A., Wrobel, G., Hahn, M., Kokocinski, F., Голанов, А. В., Joos, S., & Lichter, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3968 · Cited by 144
Self-citationGenomic Amplification of Orthodenticle Homologue 2 in Medulloblastomas
Boon, K., Eberhart, C. G., & Riggins, G. J. (2005) · Cancer Research · doi:10.1158/0008-5472.703.65.3 · Cited by 100
Self-citationIsochromosome 17q Is a Negative Prognostic Factor in Poor-Risk Childhood Medulloblastoma Patients
Pan, E., Pellarin, M., Holmes, E., Smirnov, I. V., Misra, A., Eberhart, C. G., Burger, P. C., Biegel, J. A., & Feuerstein, B. G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0465 · Cited by 89
Self-citationFOXG1 dysregulation is a frequent event in medulloblastoma
Adesina, A. M., Nguyen, Y., Mehta, V. P., Takei, H., Stangeby, P., Crabtree, S., Chintagumpala, M., & Gumerlock, M. K. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9394-3 · Cited by 63
Distinctive clinical course and pattern of relapse in adolescents with medulloblastoma
Tabori, U. Y., Sung, L., Hukin, J., Laperrière, N., Crooks, B., Carret, A., Silva, M. R., Odame, I., Mpofu, C., Strother, D. R., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.07.962 · Cited by 45
Cited by
Molecular subgroups of medulloblastoma: the current consensus
Taylor, M. D., Northcott, P. A., Korshunov, A., Remke, M., Cho, Y.-J., Clifford, S. C., Eberhart, C. G., Parsons, D. W., Rutkowski, S., Gajjar, A., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0922-z · Cited by 1,936
“Others approaches to identify Shh medulloblastomas have included immunohistochemical staining for SFRP1 [2, 28, 48], or GAB1 [11].”
BackgroundMethodInfluentialSelf-citationKillela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., Giovanella, B. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303607110 · Cited by 1,368
The whole-genome landscape of medulloblastoma subtypes
Northcott, P. A., Buchhalter, I., Morrissy, A. S., Hovestadt, V., Weischenfeldt, J., Ehrenberger, T., Gröbner, S., Segura-Wang, M., Zichner, T., Rudneva, V. A., et al. (2017) · Nature · doi:10.1038/nature22973 · Cited by 1,112
“Notable similarities between Group 3 and Group 4 have been discussed, including ambiguous cases that exhibit features characteristic of either subgroup 33–35 .”
Self-citationKool, M., Korshunov, A., Remke, M., Jones, D. T. W., Schlanstein, M., Northcott, P. A., Cho, Y.-J., Koster, J., Schouten-van Meeteren, A., van Vuurden, D., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0958-8 · Cited by 1,056
Self-citationAdvancing therapy for osteosarcoma
Gill, J., & Gorlick, R. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00519-8 · Cited by 876
Metadata
- Authors
- Northcott, P. A., Korshunov, A., Witt, H., Hielscher, T., Eberhart, C. G., Mack, S., Bouffet, E., Clifford, S. C., Hawkins, C. E., French, P., Rutka, J. T., Pfister, S., & Taylor, M. D.
- Venue
- Journal of Clinical Oncology
- Published
- 2011-04-10
- Volume
- 29
- Issue
- 11
- Pages
- 1408-1414
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2153398041
- Cited by
- 1,339
- References
- 31
- FWCI
- 39.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.